Law360, New York (May 21, 2012, 2:05 PM ET) -- Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC on Friday urged a judge to toss a suit accusing the drugmakers of deceptively marketing their blockbuster blood thinner Plavix and causing patients to overpay for the drug, claiming the plaintiffs haven’t alleged anything to support the suit.
The plaintiffs, two employee health plans, claim Bristol-Myers and Sanofi misstated both the safety and the effectiveness of Plavix. However, they haven’t identified any allegedly false statements regarding Plavix made by the drugmakers, or a single doctor or pharmacy that relied...
Bristol, Sanofi Say Plavix Marketing Suit Isn't Supported
To view the full article, take a free trial now.
